Literature DB >> 6690046

Effect of gossypol on DNA synthesis and cell cycle progression of mammalian cells in vitro.

Y Wang, P N Rao.   

Abstract

Gossypol, a yellow phenolic compound extracted from cotton plants that is being used as a male antifertility drug, has been found to have cytotoxic effects. The objective of the present study was to determine the cause of these cytotoxic effects in cultured cells and to ascertain whether cells in certain phases of the cell cycle were more sensitive to the drug than were cells in other phases. HeLa or Chinese hamster ovary cells were exposed to various concentrations of gossypol for varying periods of time, and the effects of the drug on the growth rate, cell cycle traverse, plating efficiency, and macromolecular synthesis were measured. The results of this study indicate that gossypol is a specific inhibitor of DNA synthesis; it has no effect on RNA and protein synthesis at a concentration of 10 micrograms/ml and hence has no effect on the cell cycle traverse of cells from G2 to the beginning of S phase. In the presence of the drug, cells can enter S phase but fail to complete replication. The effects of the drug on growth rate and plating efficiency indicate that there is a threshold concentration at which gossypol becomes effective as a cytotoxic agent. Gossypol did not increase chromosome aberrations in the treated cells. Since gossypol irreversibly blocks cells in S phase, it could be useful as an antitumor drug.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6690046

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Anti-inflammatory Effects of Gossypol on Human Lymphocytic Jurkat Cells via Regulation of MAPK Signaling and Cell Cycle.

Authors:  Chien-Wei Chen; Sindy Hu; Ke-Hung Tsui; Guey-Shyang Hwang; Szu-Tah Chen; Tswen-Kei Tang; Hao-Tsai Cheng; Ju-Wen Yu; Hsiao-Chiu Wang; Horng-Heng Juang; Paulus S Wang; Shyi-Wu Wang
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

Review 2.  Bcl-2 antagonists: a proof of concept for CLL therapy.

Authors:  Kumudha Balakrishnan; Varsha Gandhi
Journal:  Invest New Drugs       Date:  2013-08-02       Impact factor: 3.850

3.  The anti-angiogenic potential of (±) gossypol in comparison to suramin.

Authors:  Gönül Ulus; A Tansu Koparal; Kemal Baysal; Günay Yetik Anacak; N Ülkü Karabay Yavaşoğlu
Journal:  Cytotechnology       Date:  2018-08-19       Impact factor: 2.058

4.  Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells.

Authors:  Kumudha Balakrishnan; William G Wierda; Michael J Keating; Varsha Gandhi
Journal:  Blood       Date:  2008-06-19       Impact factor: 22.113

5.  Gossypol induces apoptosis of multiple myeloma cells through the JUN-JNK pathway.

Authors:  Luyuan Zhang; Sinan Sun; Yumin Wang; Yongzhen Mo; Fang Xiong; Shanshan Zhang; Zhaoyang Zeng; Wei Xiong; Guiyuan Li; Hao Chen; Can Guo
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

6.  Antitumor effects of gossypol on murine tumors.

Authors:  P N Rao; Y C Wang; E Lotzova; A A Khan; S P Rao; L C Stephens
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

7.  Lactic dehydrogenase isozymes, 31P magnetic resonance spectroscopy, and in vitro antimitochondrial tumor toxicity with gossypol and rhodamine-123.

Authors:  C Benz; C Hollander; M Keniry; T L James; M Mitchell
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

8.  A preliminary clinical study of gossypol in advanced human cancer.

Authors:  R C Stein; A E Joseph; S A Matlin; D C Cunningham; H T Ford; R C Coombes
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

9.  Gossypol effects on cultured normal and malignant melanocytes.

Authors:  F Hu; K Mah; D J Teramura
Journal:  In Vitro Cell Dev Biol       Date:  1986-10

10.  Gossypol inhibition of mitosis, cyclin D1 and Rb protein in human mammary cancer cells and cyclin-D1 transfected human fibrosarcoma cells.

Authors:  M Ligueros; D Jeoung; B Tang; D Hochhauser; M M Reidenberg; M Sonenberg
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.